Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05

Cytometry Part A

Volumn 87, Issue 10, 2015, Pages 967-975

  Frøsig, Thomas Mørch ^a,b,c   Yap, Jiawei ^d   Seremet, Tina ^a   Lyngaa, Rikke ^a,c   Svane, Inge Marie ^a   Thor Straten, Per ^a   Heemskerk, Mirjam H M ^e   Grotenbreg, Gijsbert M ^c,d   Hadrup, Sine Reker ^a,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD8 T cells; Conditional ligands; Flow cytometry; HLA B molecules; MHC multimer

Indexed keywords

HLA B35 ANTIGEN; HLA B8 ANTIGEN; HLA-B*08:01 ANTIGEN; HLA-B*35:01 ANTIGEN; LIGAND; PEPTIDE;

AMINO ACID SEQUENCE; CD8+ T LYMPHOCYTE; HUMAN; IMMUNOLOGY; T LYMPHOCYTE;

AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; HLA-B35 ANTIGEN; HLA-B8 ANTIGEN; HUMANS; LIGANDS; PEPTIDES; T-LYMPHOCYTES;

EID: 84942374076     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22689     Document Type: Article

References (23)

1. Andersen RS, Thrue CA, Junker N, Lyngaa R, Donia M, Ellebæk E, Svane IM, Schumacher TN, Thor Straten P, Hadrup SR. Dissection of T-cell antigen specificity in human melanoma. Cancer Res 2012;72:1642-1650.
2. Grotenbreg GM, Roan NR, Guillen E, Meijers R, Wang J-H, Bell GW, Starnbach MN, Ploegh HL. Discovery of cd8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc Natl Acad Sci USA 2008;105:3831-3836.
3. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996;274:94-96.
4. Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, Nieuwkoop NJ, van de Kasteele W, Rimmelzwaan GF, Haanen JBAG, Ovaa H, et al. Design and use of conditional MHC class I ligands. Nat Med 2006;12:246-251.
5. Rodenko B, Toebes M, Hadrup SR, van Esch WJE, Molenaar AM, Schumacher TNM, Ovaa H. Generation of peptide-MHC class I complexes through UV-mediated ligand exchange. Nat Protoc 2006;1:1120-1132.
6. Bakker AH, Hoppes R, Linnemann C, Toebes M, Rodenko B, Berkers CR, Hadrup SR, van Esch WJE, Heemskerk MHM, Ovaa H, et al. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-a1, -a3, -a11, and -b7. Proc Natl Acad Sci USA 2008;105:3825-3830.
7. Hadrup SR, Bakker AH, Shu CJ, Andersen RS, van Veluw J, Hombrink P, Castermans E, Thor Straten P, Blank C, Haanen JB, et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Methods 2009;6:520.
8. Newell EW, Klein LO, Yu W, Davis MM. Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat Methods 2009;6:497-499.
9. Newell EW, Sigal N, Nair N, Kidd BA, Greenberg HB, Davis MM. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat. Biotechnol 2013;31:623-629.
10. Chang CXL, Tan AT, Or MY, Toh KY, Lim PY, Chia ASE, Froesig TM, Nadua KD, Oh H-LJ, Leong HN, et al. Conditional ligands for Asian HLA variants facilitate the definition of cd8+ T-cell responses in acute and chronic viral diseases. Eur J Immunol 2013;43:1109-1120.
11. Marsh SGE, Parham P, Barber LD. The HLA Facts Book. London, UK: Academic Press; 2000.
12. Hadrup SR, Toebes M, Rodenko B, Bakker AH, Egan DA, Ovaa H, Schumacher TNM. High-throughput T-cell epitope discovery through MHC peptide exchange. Methods Mol Biol 2009;524:383-405.
13. Andersen RS, Kvistborg P, Frøsig TM, Pedersen NW, Lyngaa R, Bakker AH, Shu CJ, Straten Pt, Schumacher TN, Hadrup SR. Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers. Nat Protoc 2012;7:891-902.
14. Kjer-Nielsen L, Clements CS, Brooks AG, Purcell AW, Fontes MR, McCluskey J, Rossjohn J. The structure of HLA-b8 complexed to an immunodominant viral determinant: Peptide-induced conformational changes and a mode of MHC class I dimerization. J Immunol 2002;169:5153-5160.
15. Hourigan CS, Harkiolaki M, Peterson NA, Bell JI, Jones EY, O'Callaghan CA. The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: Steric hindrance influences TCR allo-recognition. Eur J Immunol 2006;36:3288-3293.
16. Theodossis A, Guillonneau C, Welland A, Ely LK, Clements CS, Williamson NA, Webb AI, Wilce JA, Mulder RJ, Dunstone MA, et al. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc. Natl Acad Sci USA 2010; 107:5534-9.
17. Van Buuren MM, Dijkgraaf FE, Linnemann C, Toebes M, Chang CXL, Mok JY, Nguyen M, van Esch WJE, Kvistborg P, Grotenbreg GM, et al. HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific cd8+ T cell responses. J Immunol 2014;192:641-648.
18. Hildebrand WH, Domena JD, Shen SY, Lau M, Terasaki PI, Bunce M, Marsh SG, Guttridge MG, Bias WB, Parham P. HLA-b15: A widespread and diverse family of HLA-B alleles. Tissue Antigens 1994;43:209-218.
19. Fleischhauer K, Avila D, Vilbois F, Traversari C, Bordignon C, Wallny HJ. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: Implications for peptide involvement in allorecognition of a single amino acid change in the HLA-b44 heavy chain. Tissue Antigens 1994;44:311-317.
20. Engels B, Engelhard VH, Sidney J, Sette A, Binder DC, Liu RB, Kranz DM, Meredith SC, Rowley DA, Schreiber H. Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell 2013;23:516-526.
21. Kammertoens T, Blankenstein T. It's the peptide-MHC affinity, stupid. Cancer Cell 2013;23:429-431.
22. Chersi A, Garzillo C, Butler RH, Tanigaki N. Allele- and temperature-dependency of in vitro HLA class I assembly. Hum Immunol 2001;62:858-868.
23. Jørgensen KW, Rasmussen M, Buus S, Nielsen M. NetMHCstab-Predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery. Immunology 2014;141:18-26.